Sharda Cropchem Ltd.

As of June 30, 2026, Sharda Cropchem Ltd. carries a market capitalization of 79.38B, placing it among publicly traded companies globally. Its enterprise value stands at 79.38B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sharda Cropchem Ltd.'s next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, Sharda Cropchem Ltd. has 90.22M shares outstanding.

As of June 30, 2026, Sharda Cropchem Ltd. trades at a trailing price-to-earnings ratio of 11.43.

As of June 30, 2026, Sharda Cropchem Ltd. trades at an EV/EBITDA multiple of 6.26 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.47 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 8.64 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 79.38B versus a market cap of 79.38B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 264.01M in revenue per employee across its workforce of 205.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Sharda Cropchem Ltd. recorded 1.94B in income tax expense. That works out to an effective tax rate of 21.79, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 8.88B, leaving 6.95B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Sharda Cropchem Ltd.'s stock has declined approximately 21.41% over the past 52 weeks. The 50-day moving average sits at 753.84, while the 200-day moving average is 918.37.

Over the twelve months ended June 30, 2026, Sharda Cropchem Ltd. generated 54.12B in revenue and converted that into 6.95B in net income, yielding earnings per share of 77.01. EBITDA reached 12.67B, while operating income came in at 9.19B.

Over the twelve months ended June 30, 2026, Sharda Cropchem Ltd. posted a gross margin of 36.28, reflecting its pricing power and cost economics. The operating margin of 16.97 and net profit margin of 12.83 provide insight into operational efficiency.